Product Code: BMIRE00028051
The South America pharmaceutical excipients market is expected to grow from US$ 348.40 million in 2022 to US$ 526.54 million by 2028. It is estimated to register a CAGR of 7.1% from 2022 to 2028.
Rising Demand and Emphasis on Co-Processed Excipients is fueling the growth of South America pharmaceutical excipients market
Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on producing co-processed and multifunctional excipients with enhanced performance. Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. They are increasingly used to convert complicated and labor-intensive formulation processes, such as wet granulation, to quick direct-compression processes, without affecting the final product quality or performance. Co-processed excipients play a crucial role in creating a stable, result-oriented drug delivery system with enhanced chemical, physical, and mechanical properties. The companies are focusing on developing co-processed excipients for drug formulations. For instance, in July 2021, DFE Pharma launched a co-processed excipient, Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). It has been developed as the synergistic solution for challenging oral solid dosage formulations. A co-processed excipient is a promising tool in the production of pharmaceutical products. Existing co-processed adjuvants cannot fulfill all the needs for the preparation of various novel formulations. There is also enough space for the production of new co-processed excipients to satisfy the demand of the pharmaceutical industries, which is expected to act as an opportunity for the growth of the South America pharmaceutical excipients market during the forecast period.
South America Pharmaceutical Excipients Market Overview
South America includes Argentina and Brazil. The pharmaceutical excipients market in the region is expected to have growth opportunities in both countries. Growing geriatric population in both countries and increasing prevalence of chronic diseases are driving the market. Moreover, developments in the healthcare industry and a rise in research and development in the pharmaceutical sector are likely to foster the market's growth during the forecast period. Hence, the need for functional excipients is growing across the country, driving the pharmaceutical excipients market in the country. Brazil is the fifth-largest country globally by area and population. The country is experiencing the fastest demographic aging and a rise in the prevalence of noncommunicable Diseases (NCD), which is expected to serve wider growth opportunities for the market. For instance, in 2020, the elderly population accounted for 30.1 million, about 14.3% of the population. In addition, as per the Brazil Statistical Institute, people aged 65 and above are expected to reach 36% by 2050. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses such as lifestyle heart disorders and other cardiovascular diseases, which may lead to increased morbidities and demand for services in the healthcare system. Most companies are increasing their presence in the Brazilian market to capture the significant potential available in the pharmaceutical excipients market.
South America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
South America Pharmaceutical Excipients Market Segmentation
The South America pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the South America pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The plant protein & polyols & cyclodextrins segment registered the largest market share in 2022.
Based on clinical indication, the South America pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.
Based on functionality, the South America pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.
Based on application, the South America pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.
Based on end user, the South America pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.
Based on country, the South America pharmaceutical excipients market is segmented into Brazil, Argentina, and the Rest of South America. Saudi Arabia dominated the market in 2022.
Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the South America pharmaceutical excipients market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America pharmaceutical excipients market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 South America Pharmaceutical Excipients Market - By Type
- 1.3.2 South America Pharmaceutical Excipients Market - By Clinical Indication
- 1.3.3 South America Pharmaceutical Excipients Market - By Functionality
- 1.3.4 South America Pharmaceutical Excipients Market - By Application
- 1.3.5 South America Pharmaceutical Excipients Market - By End User
- 1.3.6 South America Pharmaceutical Excipients Market - By Country
2. Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South America Pharmaceutical Excipients Market - Market Landscape
- 4.1 Overview
- 4.2 South America PEST Analysis
- 4.3 Experts Opinion
5. South America Pharmaceutical Excipients Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Growing Generics Market
- 5.1.2 Increasing Product Launches
- 5.2 Market Restraints
- 5.2.1 Cost and Time-Intensive Drug Development Process
- 5.3 Market Opportunities
- 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
- 5.4 Future Trends
- 5.4.1 Use of Nanotechnology to Improve Excipients Capabilities
- 5.5 Impact Analysis
6. Pharmaceutical Excipients Market - South America Analysis
- 6.1 South America Pharmaceutical Excipients Market Revenue Forecast & Analysis
7. South America Pharmaceutical Excipients Market Analysis - By Type
- 7.1 Overview
- 7.2 South America Pharmaceutical Excipients Market, By Type, 2021 & 2028 (%)
- 7.3 Bioresorbable Polymers & Lipids & Liposome-Based Formulation
- 7.3.1 Overview
- 7.3.2 Bioresorbable Polymers & Lipids & Liposome-Based Formulation: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.4 Oleochemicals
- 7.4.1 Overview
- 7.4.2 Oleochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.4.2.1 Fatty Alcohols
- 7.4.2.1.1 Overview
- 7.4.2.1.2 Fatty Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.4.2.2 Metal Stearates
- 7.4.2.2.1 Overview
- 7.4.2.2.2 Metal Stearates: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.4.2.3 Glycerine
- 7.4.2.3.1 Overview
- 7.4.2.3.2 Glycerine: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.4.2.4 Others
- 7.4.2.4.1 Overview
- 7.4.2.4.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.5 Sugars
- 7.5.1 Overview
- 7.5.1.1 Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.5.1.2 Actual Sugars
- 7.5.1.2.1 Overview
- 7.5.1.2.2 Actual Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.5.1.3 Sugar Alcohols
- 7.5.1.3.1 Overview
- 7.5.1.3.2 Sugar Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.5.1.4 Artificial Sweeteners
- 7.5.1.4.1 Overview
- 7.5.1.4.2 Artificial Sweeteners: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.6 Cellulose
- 7.6.1 Overview
- 7.6.2 Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.6.2.1 Microcrystalline Cellulose
- 7.6.2.1.1 Overview
- 7.6.2.1.2 Microcrystalline Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.6.2.2 Cellulose Ethers
- 7.6.2.2.1 Overview
- 7.6.2.2.2 Cellulose Ethers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.6.2.3 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium
- 7.6.2.3.1 Overview
- 7.6.2.3.2 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.7 Starches
- 7.7.1 Overview
- 7.7.2 Starches: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.7.2.1 Modified Starch
- 7.7.2.1.1 Modified Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.7.2.2 Dried Starch
- 7.7.2.2.1 Dried Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.7.2.3 Converted Starch and Pregelatinized Starch
- 7.7.2.3.1 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.8 Petrochemicals
- 7.8.1 Overview
- 7.8.2 Petrochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.8.2.1 Glycols
- 7.8.2.1.1 Glycols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.8.2.2 Povidones
- 7.8.2.2.1 Povidones: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.8.2.3 Mineral Hydrocarbons
- 7.8.2.3.1 Mineral Hydrocarbons: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.8.2.4 Others
- 7.8.2.4.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.9 Plant Proteins and Polyols and Cyclodextrins
- 7.9.1 Overview
- 7.9.2 Plant Proteins and Polyols and Cyclodextrins: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10 Inorganic Chemicals
- 7.10.1 Overview
- 7.10.2 Inorganic Chemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10.2.1 Magnesium and Calcium Carbonate
- 7.10.2.1.1 Magnesium and Calcium Carbonate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10.2.2 Calcium and Aluminium Phosphate
- 7.10.2.2.1 Calcium and Aluminium Phosphate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10.2.3 Silicon Dioxide
- 7.10.2.3.1 Silicon Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10.2.4 Titanium Dioxide
- 7.10.2.4.1 Titanium Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.10.2.5 Others
- 7.10.2.5.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8. South America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Clinical Indication
- 8.1 Overview
- 8.2 South America Pharmaceutical Excipient Market, By Clinical Indication, 2021 & 2028 (%)
- 8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.4 Metabolic
- 8.4.1 Overview
- 8.4.2 Metabolic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.5 Infectious Disease
- 8.5.1 Overview
- 8.5.2 Infectious Disease: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.6 Dental
- 8.6.1 Overview
- 8.6.2 Dental: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.7 Ophthalmic
- 8.7.1 Overview
- 8.7.2 Ophthalmic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.8 Gene Therapies
- 8.8.1 Overview
- 8.8.2 Gene Therapies: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9. South America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Functionality
- 9.1 Overview
- 9.2 South America Pharmaceutical Excipient Market, By Functionality, 2021 & 2028 (%)
- 9.3 Colouring Agents and Coating Agents
- 9.3.1 Overview
- 9.3.2 Colouring Agents and Coating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4 Sweetener and Flavouring Agents
- 9.4.1 Overview
- 9.4.2 Sweetener and Flavouring Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.5 Suspending and Viscosity Agents
- 9.5.1 Overview
- 9.5.2 Suspending and Viscosity Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.6 Preservative and Controlled Release
- 9.6.1 Overview
- 9.6.2 Preservative and Controlled Release: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.7 Antioxidant and Oil
- 9.7.1 Overview
- 9.7.2 Antioxidant and Oil: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.8 Tablet Filler and Diluents
- 9.8.1 Overview
- 9.8.2 Tablet Filler and Diluents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.9 Binders and Compression and Granulating Agents
- 9.9.1 Overview
- 9.9.2 Binders and Compression and Granulating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.10 Emulsifiers
- 9.10.1 Overview
- 9.10.2 Emulsifiers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 9.11 Others
- 9.11.1 Overview
- 9.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10. South America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Application
- 10.1 Overview
- 10.2 South America Pharmaceutical Excipient Market, By Application, 2021 & 2028 (%)
- 10.3 Parenteral
- 10.3.1 Overview
- 10.3.2 Parenteral: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.4 Oral Formulations & Tablets
- 10.4.1 Overview
- 10.4.2 Oral Formulations & Tablets: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5 Capsules
- 10.5.1 Overview
- 10.5.2 Capsules: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.3 Hard Gels
- 10.5.3.1 Overview
- 10.5.3.2 Hard Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.4 Soft Gels
- 10.5.4.1 Overview
- 10.5.4.2 Soft Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.6 Liquid & Injectable
- 10.6.1 Overview
- 10.6.2 Liquid & Injectable: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.7 Physiochemical Excipient-Container Interactions in Prefilled Syringes
- 10.7.1 Overview
- 10.7.2 Physiochemical Excipient-Container Interactions in Prefilled Syringes: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.8 Nutraceutical & OTC
- 10.8.1 Overview
- 10.8.2 Nutraceutical & OTC: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.9 Topical
- 10.9.1 Overview
- 10.9.2 Topical: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.10 Others
- 10.10.1 Overview
- 10.10.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11. South America Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By End User
- 11.1 Overview
- 11.2 South America Pharmaceutical Excipient Market, By End User, 2021 & 2028 (%)
- 11.3 Biopharma Industries
- 11.3.1 Overview
- 11.3.2 Biopharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 11.4 Pharma Industries
- 11.4.1 Overview
- 11.4.2 Pharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 11.5 Animal Health
- 11.5.1 Overview
- 11.5.2 Animal Health: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
12. South America Pharmaceutical Excipients Market Revenue and Forecasts to 2028 - Country Analysis
- 12.1 Overview
- 12.1.1 South America: Pharmaceutical Excipients Market, by Country, 2021 & 2028 (%)
- 12.1.1.1 Brazil: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (USD Million)
- 12.1.1.1.1 Overview
- 12.1.1.1.2 Brazil: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.1.3 Brazil: Pharmaceutical Excipients Market, by Type, 2019-2028
- 12.1.1.1.3.1 Brazil: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
- 12.1.1.1.3.2 Brazil: Pharmaceutical Excipients Market, by Sugars, 2019-2028
- 12.1.1.1.3.3 Brazil: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
- 12.1.1.1.3.4 Brazil: Pharmaceutical Excipients Market, by Starches, 2019-2028
- 12.1.1.1.3.5 Brazil: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
- 12.1.1.1.3.6 Brazil: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
- 12.1.1.1.4 Brazil: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
- 12.1.1.1.5 Brazil: Pharmaceutical Excipients Market, by Functionality, 2019-2028
- 12.1.1.1.6 Brazil: Pharmaceutical Excipients Market, by Application, 2019-2028
- 12.1.1.1.6.1 Brazil: Pharmaceutical Excipients Market, by Capsules, 2019-2028
- 12.1.1.1.7 Brazil: Pharmaceutical Excipients Market, by End User, 2019-2028
- 12.1.1.2 Argentina: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (USD Million)
- 12.1.1.2.1 Overview
- 12.1.1.2.2 Argentina: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.2.3 Argentina: Pharmaceutical Excipients Market, by Type, 2019-2028
- 12.1.1.2.3.1 Argentina: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
- 12.1.1.2.3.2 Argentina: Pharmaceutical Excipients Market, by Sugars, 2019-2028
- 12.1.1.2.3.3 Argentina: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
- 12.1.1.2.3.4 Argentina: Pharmaceutical Excipients Market, by Starches, 2019-2028
- 12.1.1.2.3.5 Argentina: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
- 12.1.1.2.3.6 Argentina: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
- 12.1.1.2.4 Argentina: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
- 12.1.1.2.5 Argentina: Pharmaceutical Excipients Market, by Functionality, 2019-2028
- 12.1.1.2.6 Argentina: Pharmaceutical Excipients Market, by Application, 2019-2028
- 12.1.1.2.6.1 Argentina: Pharmaceutical Excipients Market, by Capsules, 2019-2028
- 12.1.1.2.7 Argentina: Pharmaceutical Excipients Market, by End User, 2019-2028
- 12.1.1.3 Rest of the South America: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (USD Million)
- 12.1.1.3.1 Overview
- 12.1.1.3.2 Rest of the South America: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.3.3 Rest of the South America: Pharmaceutical Excipients Market, by Type, 2019-2028
- 12.1.1.3.3.1 Rest of the South America: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
- 12.1.1.3.3.2 Rest of the South America: Pharmaceutical Excipients Market, by Sugars, 2019-2028
- 12.1.1.3.3.3 Rest of the South America: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
- 12.1.1.3.3.4 Rest of the South America: Pharmaceutical Excipients Market, by Starches, 2019-2028
- 12.1.1.3.3.5 Rest of the South America: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
- 12.1.1.3.3.6 Rest of the South America: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
- 12.1.1.3.4 Rest of the South America: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
- 12.1.1.3.5 Rest of the South America: Pharmaceutical Excipients Market, by Functionality, 2019-2028
- 12.1.1.3.6 Rest of the South America: Pharmaceutical Excipients Market, by Application, 2019-2028
- 12.1.1.3.6.1 Rest of the South America: Pharmaceutical Excipients Market, by Capsules, 2019-2028
- 12.1.1.3.7 Rest of the South America: Pharmaceutical Excipients Market, by End User, 2019-2028
13. South America Pharmaceutical Excipients Market-Industry Landscape
- 13.1 Overview
- 13.2 Organic Developments
- 13.3 Inorganic Developments
14. Company Profile
- 14.1 JRS PHARMA GmbH & Co. KG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Roquette Freres SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 BASF SE
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Evonik Industries AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 AshLand Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Archer-Daniels-Midland Co
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 The Dow Chemical Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 The Lubrizol Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Avantor Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 MEGGLE GmbH & Co KG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
- 14.11 Univar Solutions Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms